Fournier's gangrene : What are the prognostic factors? Our experience with 40 patients
##plugins.themes.academic_pro.article.main##
Abstract
Background : Fournier's gangrene (FG) is a serious, extensive fulminant infection of the genitals and perineum. Indeed, despite antibiotics and aggressive debridement, the mortality rate of FG remains high.
Aim: Through our experience, we intent to identify effective factors in the survival of patients with FG and we try to determine how the Fournier’s gangrene severity index score (FGSIS) is accurate.
Methods: Between 1995 and 2010, 40 patients with Fournier’s gangrene were treated in our institution. All of them were treated with broadspectrum triple antimicrobial therapy, broad debridement and exhaustive cleaning. Then they underwent skin grafts or delayed closure as needed. Data were collected on demographics, medical history, predisposing factors of FG, etiological infection agents, admission signs and symptoms, physical examination, admission laboratory studies and bacteriology. Timing and degree of surgical debridement as well as outcomes were also reviewed. The extent of disease was calculated from body surface area nomograms.
Results: All the 40 patients included in this study were males; their mean age was 52,75 years (21-75 years). Twelve patients (30%) had FG secondary to anorectal pathological conditions. No etiologic factors of FG were found in 6 patients (15%). Diabetes mellitus as predisposing factor was found in 13 patients (32.5%). The mean hospital stay was 8.72 days (range, 3 to 30). All the patients underwent surgical debridement. Orchidectomy was done in 7 cases (17.5%). Skin grafts were applied to 6 patients (15%) and the remaining wounds, once cleaned, were approximated. The overall mortality rate was 17.5% (7 patients) due to
severe metabolic acidosis in relation to diabetic decompensation and sepsis.
We individualized two groups: those who died (n = 7) and those who survived (n = 33). We evaluated the admission laboratory parameters that are significantly correlated with outcome included hematocrit (p=0.003) and serum sodium (p=0.05). The extent of body surface area involved among patients who died was not found significantly different statistically between the two groups (4.07% and 3,14%, p=0,4). The mean FGSIS (without counting bicarbonate serum level) for survivors was 9.1 compared with 6,8 for nonsurvivors (p=0.16).
Conclusion: FG is a rapidly progressive, fulminant infection’s condition. Hematocrit and serum sodium levels were found to be the only prognostic factors. It doesn’t seem that the FGSIS has a prognostic value.
Aim: Through our experience, we intent to identify effective factors in the survival of patients with FG and we try to determine how the Fournier’s gangrene severity index score (FGSIS) is accurate.
Methods: Between 1995 and 2010, 40 patients with Fournier’s gangrene were treated in our institution. All of them were treated with broadspectrum triple antimicrobial therapy, broad debridement and exhaustive cleaning. Then they underwent skin grafts or delayed closure as needed. Data were collected on demographics, medical history, predisposing factors of FG, etiological infection agents, admission signs and symptoms, physical examination, admission laboratory studies and bacteriology. Timing and degree of surgical debridement as well as outcomes were also reviewed. The extent of disease was calculated from body surface area nomograms.
Results: All the 40 patients included in this study were males; their mean age was 52,75 years (21-75 years). Twelve patients (30%) had FG secondary to anorectal pathological conditions. No etiologic factors of FG were found in 6 patients (15%). Diabetes mellitus as predisposing factor was found in 13 patients (32.5%). The mean hospital stay was 8.72 days (range, 3 to 30). All the patients underwent surgical debridement. Orchidectomy was done in 7 cases (17.5%). Skin grafts were applied to 6 patients (15%) and the remaining wounds, once cleaned, were approximated. The overall mortality rate was 17.5% (7 patients) due to
severe metabolic acidosis in relation to diabetic decompensation and sepsis.
We individualized two groups: those who died (n = 7) and those who survived (n = 33). We evaluated the admission laboratory parameters that are significantly correlated with outcome included hematocrit (p=0.003) and serum sodium (p=0.05). The extent of body surface area involved among patients who died was not found significantly different statistically between the two groups (4.07% and 3,14%, p=0,4). The mean FGSIS (without counting bicarbonate serum level) for survivors was 9.1 compared with 6,8 for nonsurvivors (p=0.16).
Conclusion: FG is a rapidly progressive, fulminant infection’s condition. Hematocrit and serum sodium levels were found to be the only prognostic factors. It doesn’t seem that the FGSIS has a prognostic value.
Keywords:
Fournier's gangrene, necrotizing fascitis, idiopathic, etiology, treatment, outcome, mortality, prognosis.##plugins.themes.academic_pro.article.details##
References
- Yeniyol CO, Suelozgen T, Arslan M, Ayder AR. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score. Urology 2004;64:218-22.
- Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995; 154: 89-92.
- Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. Br J Urol 1998;81: 347-55.
- Eke N. Fournier's gangrene: A review of 1726 cases. Br J Surg 2000;87: 718-28.
- Spirnak JP, Resnick MI, Hampel N, Persky L. Fournier's gangrene: Report of 20 patients. J Urol 1984; 131: 289-91.
- Lamb RC, Juler GL. Fournier's gangrene of the scrotum. A poorly defined syndrome or a misnomer. Arch Surg 1983; 118: 38-40.
- Fahal AH, Hassan MA. Fournier's gangrene in Khartoum. Br J Urol 1988; 61: 451-4.
- Flanigan RC, Kursh ED, McDougal WS, Persky L. Synergistic gangrene of the scrotum and penis secondary to colorectal disease. J Urol 1978; 119: 369-71.
- Villanueva-Sáenz E, MartÃnez Hernández-Magro P, Valdés Ovalle M, Montes Vega J, Alvarez-Tostado F JF. Experience in management of Fournier's gangrene. Tech Coloproctol 2002; 6:5- 10.
- Hejase MJ, Simonin JE, Bihrle R, Coogan CL. Genital Fournier's gangrene: Experience with 38 patients. Urology 1996; 47:734-9.
- Benizri E, Fabiani P, Migliori G, et al. Gangrene of perineum. Urology 1996;47:935-9.
- Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presentation and outcome of Fournier's gangrene. J Urol 2002;60:775-9.
- Clayton MD, Fowler JE Jr, Sharifi R, Pearl RK. Causes, presentation and survival of fifty-seven patients with necrotizing fascitis of the male genitalia. Surg Gynecol Obstet 1990; 170:49- 55.
- Paty R, Smith AD. Gangrene and Fournier's gangrene. Urol Clin North Am 1992; 19: 149-55.
- Ghnnam WM. Fournier's gangrene in Mansoura Egypt: A review of 74 cases. J Postgrad Med 2008;54:106-9.
- Chawla SN, Gallop C, Mydlo JH. Fournier's gangrene: An analysis of repeated surgical debridement. Eur Urol 2003;43:572- 5
- Faucher LD, Morris SE, Edelman LS, Saffle JR. Burn center management of necrotizing soft-tissue surgical infection in unburned patients. Am J Surg 2001;182:563-9.
- Wolach MD, MacDermott JP, Stone AR, deVere White RW. Treatment and complications of Fournier's gangrene. Br J Urol 1989;64:310-4.
- Ayan F, Sunamak O, Paksoy SM, et al. Fournier's gangrene: A retrospective clinical study of forty one patients. ANZ J Surg 2005;75:1055-8.
- Palmer LS, Winter HI, Tolia BB, Reid RE, Laor E. The limited impact of involved surface area on survival in Fournier's gangrene. Br J Urol 1995;76:208-12.
- Hollabaugh RS Jr, Domochowski RR, Hickerson WL, Cox CE. Foumier's gangrene: Therapeutic impact of hyperharic oxygen. Plast Reconstr Surg 1998;10:1194-100.
- Lucca M, Unger HD, Devenny AM. Treatment of Fournier's gangrene with adjunctive hyperbaric oxygen therapy. Am J Emerg Med 1990; 8: 385-7.
- Curreri PW, Luterman A: Burns, in Schwartz SI, Shires GT, and Spencer FC (Eds): Principles of Surgery. New York, McGraw Hill, 1989: 285-306.
- Korkut M, Içöz G, Dayangaç M, et al. Outcome analysis in patients with Fournier's gangrene: Report of 45 cases. Dis Colon Rectum 2003;46:649-52.
- Fillo J, Cervenakov I, Labas P, et al. Fournier's gangrene: Can aggressive treatment save life? Int Urol Nephrol 2001;33:533-6.
- Safioleas M, Stamatakos M, Mouzopoulos G, Diab A, Kontzoglou K, Papachristodoulou A.. Fournier's gangrene: Exists and it is still lethal. Int Urol Nephrol 2006;38:653-7.
- Taviloglu K, Cabioglu N, Cagatay A, et al. Idiopathic necrotizing fasciitis: Risk factors and strategies for management. Am Surg 2005;71:315-20.